"Estradiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
Descriptor ID |
D004958
|
MeSH Number(s) |
D04.210.500.365.415.248 D06.472.334.851.437.500
|
Concept/Terms |
Estradiol- Estradiol
- Estradiol-17 beta
- Estradiol 17 beta
- Estradiol Anhydrous
- Oestradiol
- Estradiol-17beta
- Estradiol 17beta
- 17 beta-Estradiol
- 17 beta Estradiol
- 17 beta-Oestradiol
- 17 beta Oestradiol
|
Below are MeSH descriptors whose meaning is more general than "Estradiol".
Below are MeSH descriptors whose meaning is more specific than "Estradiol".
This graph shows the total number of publications written about "Estradiol" by people in this website by year, and whether "Estradiol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 5 | 10 |
1995 | 9 | 6 | 15 |
1996 | 6 | 6 | 12 |
1997 | 9 | 10 | 19 |
1998 | 3 | 8 | 11 |
1999 | 5 | 10 | 15 |
2000 | 6 | 22 | 28 |
2001 | 12 | 8 | 20 |
2002 | 4 | 14 | 18 |
2003 | 15 | 10 | 25 |
2004 | 13 | 9 | 22 |
2005 | 14 | 9 | 23 |
2006 | 4 | 13 | 17 |
2007 | 3 | 9 | 12 |
2008 | 8 | 9 | 17 |
2009 | 10 | 3 | 13 |
2010 | 9 | 13 | 22 |
2011 | 9 | 12 | 21 |
2012 | 8 | 8 | 16 |
2013 | 6 | 12 | 18 |
2014 | 9 | 13 | 22 |
2015 | 2 | 3 | 5 |
2016 | 12 | 8 | 20 |
2017 | 5 | 11 | 16 |
2018 | 4 | 9 | 13 |
2019 | 3 | 4 | 7 |
2020 | 2 | 10 | 12 |
2021 | 3 | 7 | 10 |
2022 | 3 | 4 | 7 |
2023 | 1 | 4 | 5 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Estradiol" by people in Profiles.
-
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study. Clin Cancer Res. 2024 Dec 02; 30(23):5304-5313.
-
Identification of an ionic mechanism for ERa-mediated rapid excitation in neurons. Sci Adv. 2024 Oct 04; 10(40):eadp0696.
-
TFEB controls syncytiotrophoblast formation and hormone production in placenta. Cell Death Differ. 2024 Nov; 31(11):1439-1451.
-
Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver Int. 2024 Feb; 44(2):460-471.
-
Estradiol mediates colonic epithelial protection in aged mice after stroke and is associated with shifts in the gut microbiome. Gut Microbes. 2023 12; 15(2):2271629.
-
TRIM28 modulates nuclear receptor signaling to regulate uterine function. Nat Commun. 2023 08 01; 14(1):4605.
-
17?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer. Proc Natl Acad Sci U S A. 2023 06 06; 120(23):e2122053120.
-
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 05 01; 9(5):664-672.
-
Estrogen Receptor Signaling in the Immune System. Endocr Rev. 2023 01 12; 44(1):117-141.
-
Hormonal status effects on the electrophysiological correlates of performance monitoring in women. Psychoneuroendocrinology. 2023 03; 149:106006.